Global Diabetes Care Drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The global diabetes care drug market is projected to grow at a CAGR of over 4% during the forecast period. Diabetes is among the major health issues across the globe and it has reached alarming levels. The key factor that drives the growth of the market includes the increasing prevalence of diabetes across the globe. As per the International Diabetes Federation (IDF), around 463 million peoples had diabetes globally in 2019. The global prevalence of diabetes is projected to augment to 578 million by 2030, and 700 million by 2045. It is expected that around 4 million mortalities were observed in 2019 in the age range of 20–79 years;in addition to this, more than one million children and adolescents are living with type 1 diabetes.
Request a Free Sample of our Global Diabetes Care Drugs Market : https://www.omrglobal.com/request-sample/diabetes-care-drugs-market
As per IDF, the annual global health expenditure on diabetes was around $760 billion in 2019. It is further estimated to reach $825 billion by 2030 and $845 billion by 2045. The expenditure includes consulting services, drugs and device costs, and other additional costs. There are different ways to treat diabetes which include weight loss, healthy eating, regular exercise, diabetes medication, or insulin therapy.Thus, this is likely to enhance the adoption of diabetes care drugs and thereby drives the market growth during the forecast period. However, the availability of alternatives such as diabetes care devices such as insulin pumps and others is projected to hamper market growth during the forecast period.
A full Report of Global Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/diabetes-care-drugs-market
Global Diabetes Care Drugs Market Segmentation
By Drug Class
Insulins
Non-Insulin Injectable Drugs
Oral Anti-Diabetic Drugs
Combination Drugs
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
Astellas Pharma Inc.
AstraZeneca Plc
Bayer AG
Bausch Health Companies Inc.
Biocon Ltd.
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
Eli Lilly and Co.
Generex Biotechnology Corp.
Johnson & Johnson Services Inc.
Merck & Co. Inc.
Midatech Pharma Plc
Mylan NV
Novartis International AG
Novo Nordisk A/S
Oramed Pharmaceuticals Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceuticals Co.Ltd.
Teva Pharmaceuticals Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/diabetes-care-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment